BioCentury | May 15, 2018
Translation in Brief

Sustained delivery

Researchers from Vanderbilt University School of Medicine and Baylor College of Medicine have developed a new method for stable, long-term delivery of therapeutic proteins using antigen-specific T cells whose genomes have been modified with a...
BioCentury | Apr 10, 2014
Cover Story

Pre-EMP-tive strike against GBM

University of California, Los Angeles researchers have treated glioblastoma in mice by inhibiting epithelial membrane protein 2 . 1 The findings open up a new indication for spinout Paganini Biopharma Inc. , which has a mAb against...
BioCentury | Oct 16, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer TEK tyrosine kinase, endothelial (TEK; Tie2) Studies in mice suggest that tumor-targeting cell-based delivery of interferon-a (IFN-a) could offer...
BioCentury | Jun 26, 2008
Targets & Mechanisms

Prostate of Mind

Neuropeptide hormones associated with pleasure and analgesia may have an unexpected role in fighting prostate cancer, according to a report in the Proceedings of the National Academy of Sciences . 1 The study ties together a...
BioCentury | Nov 10, 2003
Company News

Peptimmune management update

...Cambridge, Mass. Business: Autoimmune Hired: Thomas Mathers as president, formerly president and CEO of Cell Based Delivery WIR...
BioCentury | Mar 31, 2003
Company News

Cell Based Delivery gene/cell therapy news

...return as much money as it can to investors, including the state of Rhode Island. Cell Based Delivery...
...were laid off. The company said the technology will probably be returned to Brown University. Cell Based Delivery...
BioCentury | Dec 16, 2002
Company News

Cell Based Delivery management update

Cell Based Delivery Inc. , Providence, R.I. Business: Hematology, Musculoskeletal Hired: Thomas Mathers as president, CEO and a director, formerly VP and general manager of Cardion Pharmaceuticals Inc. WIR Staff...
BioCentury | Dec 9, 2002
Company News

Cell Based Delivery names Mathers as CEO

Cell Based Delivery (Providence, R.I.), a developer of implantable protein delivery systems for hematology, musculoskeletal disorders hired Thomas Mathers as president, CEO and a director. Prior, he was VP and general manager of Cardion . BC...
BioCentury | Jan 4, 2000
Company News

Cell Based Delivery other research news

...tissue to deliver therapeutic proteins such as growth hormone, insulin-like growth factor-1 and angiogenesis-inducing proteins. Cell Based Delivery Inc....
BioCentury | Dec 22, 1997
Finance

Limping

...turned off the tap, monies still runneth from the private well. On the U.S. side, Cell Based Delivery...
Items per page:
1 - 10 of 13
BioCentury | May 15, 2018
Translation in Brief

Sustained delivery

Researchers from Vanderbilt University School of Medicine and Baylor College of Medicine have developed a new method for stable, long-term delivery of therapeutic proteins using antigen-specific T cells whose genomes have been modified with a...
BioCentury | Apr 10, 2014
Cover Story

Pre-EMP-tive strike against GBM

University of California, Los Angeles researchers have treated glioblastoma in mice by inhibiting epithelial membrane protein 2 . 1 The findings open up a new indication for spinout Paganini Biopharma Inc. , which has a mAb against...
BioCentury | Oct 16, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer TEK tyrosine kinase, endothelial (TEK; Tie2) Studies in mice suggest that tumor-targeting cell-based delivery of interferon-a (IFN-a) could offer...
BioCentury | Jun 26, 2008
Targets & Mechanisms

Prostate of Mind

Neuropeptide hormones associated with pleasure and analgesia may have an unexpected role in fighting prostate cancer, according to a report in the Proceedings of the National Academy of Sciences . 1 The study ties together a...
BioCentury | Nov 10, 2003
Company News

Peptimmune management update

...Cambridge, Mass. Business: Autoimmune Hired: Thomas Mathers as president, formerly president and CEO of Cell Based Delivery WIR...
BioCentury | Mar 31, 2003
Company News

Cell Based Delivery gene/cell therapy news

...return as much money as it can to investors, including the state of Rhode Island. Cell Based Delivery...
...were laid off. The company said the technology will probably be returned to Brown University. Cell Based Delivery...
BioCentury | Dec 16, 2002
Company News

Cell Based Delivery management update

Cell Based Delivery Inc. , Providence, R.I. Business: Hematology, Musculoskeletal Hired: Thomas Mathers as president, CEO and a director, formerly VP and general manager of Cardion Pharmaceuticals Inc. WIR Staff...
BioCentury | Dec 9, 2002
Company News

Cell Based Delivery names Mathers as CEO

Cell Based Delivery (Providence, R.I.), a developer of implantable protein delivery systems for hematology, musculoskeletal disorders hired Thomas Mathers as president, CEO and a director. Prior, he was VP and general manager of Cardion . BC...
BioCentury | Jan 4, 2000
Company News

Cell Based Delivery other research news

...tissue to deliver therapeutic proteins such as growth hormone, insulin-like growth factor-1 and angiogenesis-inducing proteins. Cell Based Delivery Inc....
BioCentury | Dec 22, 1997
Finance

Limping

...turned off the tap, monies still runneth from the private well. On the U.S. side, Cell Based Delivery...
Items per page:
1 - 10 of 13